What are the latest treatments for gbm
Ask Navis about your situation
This answer is general. Get one about your specific case — no signup, answered right here.
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Latest GBM Treatments
Glioblastoma (GBM) is one of the most aggressive brain cancers, and treatment approaches have evolved significantly. Here's what you should know about current standard approaches:
Standard Treatment Framework
According to NCCN Guidelines for Central Nervous System Cancers, the typical approach for newly diagnosed GBM includes:
Surgery + Radiation + Chemotherapy:
- Maximal safe surgical resection (removing as much tumor as safely possible)
- Radiation therapy (typically 6 weeks of daily treatment)
- Temozolomide (TMZ) chemotherapy during and after radiation
- This combination is considered the standard of care for most newly diagnosed patients
Emerging & Newer Approaches
Tumor-Treating Fields (TTF):
- FDA-approved device (Optune) that delivers electrical fields to slow tumor cell division
- Used alongside chemotherapy for newly diagnosed GBM
- Has shown benefit in extending survival when combined with standard treatment
Immunotherapy Research:
- Checkpoint inhibitors (like pembrolizumab, nivolumab) are being studied
- Currently NOT standard first-line treatment, but active clinical trials are ongoing
- The American Cancer Society notes this remains an area of active investigation
Targeted Therapies (if applicable):
- For tumors with specific mutations (MGMT methylation status, IDH mutations), treatment may be tailored
- Your pathology report will indicate if your tumor has these markers
Bevacizumab (Avastin):
- An anti-angiogenic drug (blocks blood vessel formation to tumors)
- May be considered for recurrent GBM or certain newly diagnosed cases
- ASCO guidelines note this as an option in specific scenarios
What You Should Ask Your Oncologist
- What is my tumor's molecular profile? (MGMT status, IDH mutation status, etc.)
- Am I a candidate for maximal surgical resection, and what are the risks/benefits?
- Should I receive Tumor-Treating Fields (TTF) therapy alongside my standard treatment?
- Are there clinical trials available for my specific situation?
- What is the treatment timeline, and what side effects should I expect?
Finding Clinical Trials
GBM has many active clinical trials testing newer approaches:
- ClinicalTrials.gov - Search "glioblastoma" for current trials
- NCI Cancer Clinical Trials - National Cancer Institute's trial finder
- Ask your oncologist which trials you might be eligible for
Important Context
Treatment decisions depend heavily on:
- Your age and overall health
- Tumor location and extent of resection possible
- Molecular characteristics of your tumor
- Your personal preferences and goals of care
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
Is there a specific aspect of GBM treatment you'd like to understand better, or do you have test results you'd like help interpreting?
Ask Navis about your case
That answer is general. Ask about your specific situation — no signup, answered right here.
Facing this with someone you love?
Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.
Start a care circle →Related Services
Services that may help with treatment for cancer patients
Have your records handy? Upload them for a deeper, personalized analysis →
Related Questions
Just finished the perspective therapeutics VMT-a-NET phase 1b dosing trial These are the results of my latest PET...
TL;DR: Your latest PET scan shows your cancer is stable—the tumors in your liver are about the same size as before, no new tumors appeared, and the tr
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...
```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv
We are in the UK royal marsden. It is kind of hopeless or how to say? Is there any immunetherapy worth to pursue or...
TL;DR: Diffuse midline gliomas DMGs with H3K27M are very challenging, but immunotherapy and targeted approaches are actively being researched—the Roya
It is my daughter she completed 6 weeks of radio and tmz now she is on 3rd cycle of tmz 200mg. We are doing low meth...
TL;DR: Your daughter's treatment plan radiation + TMZ chemotherapy is standard for diffuse midline glioma, and her biomarkers MGMT methylated, EGFR A2